Burgos J S, Vera-Sempere F J
Centro de Biología Molecular Severo Ochoa CSIC, Universidad Autónoma de Madrid, Cantoblanco, Spain.
Laryngoscope. 2000 Dec;110(12):2081-4. doi: 10.1097/00005537-200012000-00020.
OBJECTIVES/HYPOTHESIS: The aim of this study was to analyze the relevance of the CD21 membrane receptor in nasopharyngeal carcinoma (NPC). CD21 is implicated in the introduction of the Epstein-Barr virus (EBV) genome into epithelial cells and B lymphocytes.
Immunohistochemical analysis of CD21 in NPC.
Paraffin-embedded samples of NPC of different histological types with demonstrated presence of EBV were analyzed for CD21 expression using immunohistochemistry.
We detected EBV by non-isotopic in situ hybridization (NISH) and nested polymerase chain reaction (PCR) in 100% of samples, regardless of histological type, supporting the previous view that all the types of NPC are variants of an EBV-associated malignancy. CD21 was not detected in NPC, and this absence was a typical feature in our data group.
The loss of the CD21 membrane receptor could be one of the immunophenotypical changes of the neoplastic cells that occur in the evolution of the NPC malignancy.
目的/假设:本研究旨在分析CD21膜受体在鼻咽癌(NPC)中的相关性。CD21与爱泼斯坦-巴尔病毒(EBV)基因组导入上皮细胞和B淋巴细胞有关。
对鼻咽癌中的CD21进行免疫组织化学分析。
使用免疫组织化学对不同组织学类型且已证实存在EBV的鼻咽癌石蜡包埋样本进行CD21表达分析。
我们通过非同位素原位杂交(NISH)和巢式聚合酶链反应(PCR)在100%的样本中检测到EBV,无论组织学类型如何,这支持了先前的观点,即所有类型的鼻咽癌都是EBV相关恶性肿瘤的变体。在鼻咽癌中未检测到CD21,且这种缺失是我们数据组中的一个典型特征。
CD21膜受体的缺失可能是鼻咽癌恶性肿瘤演变过程中肿瘤细胞发生的免疫表型变化之一。